Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Shweta Maniar, global director, life sciences strategy & solutions for Google Cloud, recently discussed with GEN Edge the survey and the broader challenges faced by life sciences and healthcare users ...

Researchers say the deep learning model may help to create leads for new cancer diagnostics, patient stratification, and future therapies.

CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.

HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.

The conversion of large-scale, complex mass spectrometry data into meaningful structural insights through ChemEcho, a machine learning embedding method, published in August by investigators at ...

Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

A new predictive framework reprograms T cells to sustain immune memory while preserving their ability to fight cancer and infections.

The license enables Bionova to integrate the Clean Genome strain into its pDNA production workflows to support client programs.